| Spirig HealthCare AG - Mirabegron Spirig HC retard 25 mg, Retardtabletten | | 70872 | | 01 | | Mirabegron Spirig HC retard 25 mg | | Retardtabletten | | G04BD12 | | Mirabegron | | 20.10.2026 | | |
| | Composition | | mirabegronum 25 mg, macrogolum 2'000'000, cellulosum microcristallinum, hypromellosum, hydroxypropylcellulosum, E 321, magnesii stearas, silica colloidalis anhydrica, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, pro compresso obducto. | | Packungsbestandteile | | Delayed release tablets | | | | Active Agent | Dose |
|---|
| Mirabegronum | 25 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Cellulosum Microcristallinum | | | | E 171 | | color. | | E 321 | | | | Hydroxypropylcellulosum | | | | Hypromellosum | | | | Macrogol | 3350 | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 30 | | | B | | Yes | | 002 | 90 | | | B | | Yes |
|
|
